Grape	B-Organism_substance
seed	I-Organism_substance
extract	I-Organism_substance
inhibits	O
angiogenesis	O
via	O
suppression	O
of	O
the	O
vascular	O
endothelial	O
growth	O
factor	O
receptor	O
signaling	O
pathway	O
.	O

Blockade	O
of	O
angiogenesis	O
is	O
an	O
important	O
approach	O
for	O
cancer	B-Cancer
treatment	O
and	O
prevention	O
.	O

Vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
is	O
one	O
of	O
the	O
most	O
critical	O
factors	O
that	O
induce	O
angiogenesis	O
and	O
has	O
thus	O
become	O
an	O
attractive	O
target	O
for	O
antiangiogenesis	O
treatment	O
.	O

However	O
,	O
most	O
current	O
anti	O
-	O
VEGF	O
agents	O
often	O
cause	O
some	O
side	O
effects	O
when	O
given	O
chronically	O
.	O

Identification	O
of	O
naturally	O
occurring	O
VEGF	O
inhibitors	O
derived	O
from	O
diet	O
would	O
be	O
one	O
alternative	O
approach	O
with	O
an	O
advantage	O
of	O
known	O
safety	O
.	O

Grape	B-Organism_substance
seed	I-Organism_substance
extract	I-Organism_substance
(	O
GSE	B-Organism_substance
)	O
,	O
a	O
widely	O
used	O
dietary	O
supplement	O
,	O
is	O
known	O
to	O
have	O
antitumor	B-Cancer
activity	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
explored	O
the	O
activity	O
of	O
GSE	B-Organism_substance
on	O
VEGF	O
receptor	O
and	O
angiogenesis	O
.	O

We	O
found	O
that	O
GSE	B-Organism_substance
could	O
directly	O
inhibit	O
the	O
kinase	O
activity	O
of	O
purified	O
VEGF	O
receptor	O
2	O
,	O
a	O
novel	O
activity	O
of	O
GSE	B-Organism_substance
that	O
has	O
not	O
been	O
characterized	O
.	O

GSE	B-Organism_substance
could	O
also	O
inhibit	O
the	O
VEGF	O
receptor	O
/	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
-	O
mediated	O
signaling	O
pathway	O
in	O
endothelial	B-Cell
cells	I-Cell
.	O

As	O
a	O
result	O
,	O
GSE	B-Organism_substance
could	O
inhibit	O
VEGF	O
-	O
induced	O
endothelial	B-Cell
cell	I-Cell
proliferation	O
and	O
migration	O
as	O
well	O
as	O
sprout	B-Tissue
formation	O
from	O
aorta	B-Multi-tissue_structure
ring	I-Multi-tissue_structure
.	O

In	O
vivo	O
assay	O
further	O
showed	O
that	O
GSE	B-Organism_substance
could	O
inhibit	O
tumor	B-Cancer
growth	O
and	O
tumor	B-Cancer
angiogenesis	O
of	O
MDA	B-Cell
-	I-Cell
MB	I-Cell
-	I-Cell
231	I-Cell
breast	I-Cell
cancer	I-Cell
cells	I-Cell
in	O
mice	O
.	O

Consistent	O
with	O
the	O
in	O
vitro	O
data	O
,	O
GSE	B-Organism_substance
treatment	O
of	O
tumor	B-Cancer
-	O
bearing	O
mice	O
led	O
to	O
concomitant	O
reduction	O
of	O
blood	B-Multi-tissue_structure
vessel	I-Multi-tissue_structure
density	O
and	O
phosphorylation	O
of	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
.	O

Depletion	O
of	O
polyphenol	O
with	O
polyvinylpyrrolidone	O
abolished	O
the	O
antiangiogenic	O
activity	O
of	O
GSE	B-Organism_substance
,	O
suggesting	O
a	O
water	O
-	O
soluble	O
fraction	O
of	O
polyphenol	O
in	O
GSE	B-Organism_substance
is	O
responsible	O
for	O
the	O
antiangiogenic	O
activity	O
.	O

Taken	O
together	O
,	O
this	O
study	O
indicates	O
that	O
GSE	B-Organism_substance
is	O
a	O
well	O
-	O
tolerated	O
and	O
inexpensive	O
natural	O
VEGF	O
inhibitor	O
and	O
could	O
potentially	O
be	O
useful	O
in	O
cancer	B-Cancer
prevention	O
or	O
treatment	O
.	O

